Higher order chromatin organization in cancer

Research output: Contribution to journalArticle

Abstract

In spite of our increased understanding of how genomes are dysregulated in cancer and a plethora of molecular diagnostic tools, the front line and 'gold standard' detection of cancer remains the pathologist's detection of gross changes in cellular and tissue structure, most strikingly nuclear dis-organization. In fact, for over 140 years it has been noted that nuclear morphology is often disrupted in cancer. Even today, nuclear morphology measures include nuclear size, shape, DNA content (ploidy) and 'chromatin organization'. Given the importance of nuclear shape to diagnoses of cancer phenotypes, it is surprising and frustrating that we currently lack a detailed understanding to explain these changes and how they might arise and relate to molecular events in the cell. It is an implicit hypothesis that perturbation of chromatin and epigenetic signatures may lead to alterations in nuclear structure (or vice versa) and that these perturbations lie at the heart of cancer genesis. In this review, we attempt to synthesize research leading to our current understanding on how chromatin interactions at the nuclear lamina, epigenetic modulation and gene regulation may intersect in cancer and offer a perspective on critical experiments that would help clarify how nuclear architecture may contribute to the cancerous phenotype. We also discuss the historical understanding of nuclear structure in normal cells and as a diagnostic in cancer.

Original languageEnglish (US)
Pages (from-to)109-115
Number of pages7
JournalSeminars in Cancer Biology
Volume23
Issue number2
DOIs
StatePublished - Apr 2013

Fingerprint

Chromatin
Neoplasms
Epigenomics
Nuclear Lamina
Phenotype
Heart Neoplasms
Molecular Pathology
Ploidies
Cellular Structures
Genome
DNA
Research
Genes

Keywords

  • Cancer
  • ChIP
  • Chromatin
  • Chromosome
  • DamID
  • Development
  • DNA methylation
  • Epigenetics
  • Fluorescence in situ hybridization (FISH)
  • Hi-C
  • Histone
  • Lamina Associated Domain
  • Nuclear lamina

ASJC Scopus subject areas

  • Cancer Research

Cite this

Higher order chromatin organization in cancer. / Reddy, Karen L; Feinberg, Andrew P.

In: Seminars in Cancer Biology, Vol. 23, No. 2, 04.2013, p. 109-115.

Research output: Contribution to journalArticle

@article{07d1626e8734452b9cc5366105fb5e81,
title = "Higher order chromatin organization in cancer",
abstract = "In spite of our increased understanding of how genomes are dysregulated in cancer and a plethora of molecular diagnostic tools, the front line and 'gold standard' detection of cancer remains the pathologist's detection of gross changes in cellular and tissue structure, most strikingly nuclear dis-organization. In fact, for over 140 years it has been noted that nuclear morphology is often disrupted in cancer. Even today, nuclear morphology measures include nuclear size, shape, DNA content (ploidy) and 'chromatin organization'. Given the importance of nuclear shape to diagnoses of cancer phenotypes, it is surprising and frustrating that we currently lack a detailed understanding to explain these changes and how they might arise and relate to molecular events in the cell. It is an implicit hypothesis that perturbation of chromatin and epigenetic signatures may lead to alterations in nuclear structure (or vice versa) and that these perturbations lie at the heart of cancer genesis. In this review, we attempt to synthesize research leading to our current understanding on how chromatin interactions at the nuclear lamina, epigenetic modulation and gene regulation may intersect in cancer and offer a perspective on critical experiments that would help clarify how nuclear architecture may contribute to the cancerous phenotype. We also discuss the historical understanding of nuclear structure in normal cells and as a diagnostic in cancer.",
keywords = "Cancer, ChIP, Chromatin, Chromosome, DamID, Development, DNA methylation, Epigenetics, Fluorescence in situ hybridization (FISH), Hi-C, Histone, Lamina Associated Domain, Nuclear lamina",
author = "Reddy, {Karen L} and Feinberg, {Andrew P}",
year = "2013",
month = "4",
doi = "10.1016/j.semcancer.2012.12.001",
language = "English (US)",
volume = "23",
pages = "109--115",
journal = "Seminars in Cancer Biology",
issn = "1044-579X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Higher order chromatin organization in cancer

AU - Reddy, Karen L

AU - Feinberg, Andrew P

PY - 2013/4

Y1 - 2013/4

N2 - In spite of our increased understanding of how genomes are dysregulated in cancer and a plethora of molecular diagnostic tools, the front line and 'gold standard' detection of cancer remains the pathologist's detection of gross changes in cellular and tissue structure, most strikingly nuclear dis-organization. In fact, for over 140 years it has been noted that nuclear morphology is often disrupted in cancer. Even today, nuclear morphology measures include nuclear size, shape, DNA content (ploidy) and 'chromatin organization'. Given the importance of nuclear shape to diagnoses of cancer phenotypes, it is surprising and frustrating that we currently lack a detailed understanding to explain these changes and how they might arise and relate to molecular events in the cell. It is an implicit hypothesis that perturbation of chromatin and epigenetic signatures may lead to alterations in nuclear structure (or vice versa) and that these perturbations lie at the heart of cancer genesis. In this review, we attempt to synthesize research leading to our current understanding on how chromatin interactions at the nuclear lamina, epigenetic modulation and gene regulation may intersect in cancer and offer a perspective on critical experiments that would help clarify how nuclear architecture may contribute to the cancerous phenotype. We also discuss the historical understanding of nuclear structure in normal cells and as a diagnostic in cancer.

AB - In spite of our increased understanding of how genomes are dysregulated in cancer and a plethora of molecular diagnostic tools, the front line and 'gold standard' detection of cancer remains the pathologist's detection of gross changes in cellular and tissue structure, most strikingly nuclear dis-organization. In fact, for over 140 years it has been noted that nuclear morphology is often disrupted in cancer. Even today, nuclear morphology measures include nuclear size, shape, DNA content (ploidy) and 'chromatin organization'. Given the importance of nuclear shape to diagnoses of cancer phenotypes, it is surprising and frustrating that we currently lack a detailed understanding to explain these changes and how they might arise and relate to molecular events in the cell. It is an implicit hypothesis that perturbation of chromatin and epigenetic signatures may lead to alterations in nuclear structure (or vice versa) and that these perturbations lie at the heart of cancer genesis. In this review, we attempt to synthesize research leading to our current understanding on how chromatin interactions at the nuclear lamina, epigenetic modulation and gene regulation may intersect in cancer and offer a perspective on critical experiments that would help clarify how nuclear architecture may contribute to the cancerous phenotype. We also discuss the historical understanding of nuclear structure in normal cells and as a diagnostic in cancer.

KW - Cancer

KW - ChIP

KW - Chromatin

KW - Chromosome

KW - DamID

KW - Development

KW - DNA methylation

KW - Epigenetics

KW - Fluorescence in situ hybridization (FISH)

KW - Hi-C

KW - Histone

KW - Lamina Associated Domain

KW - Nuclear lamina

UR - http://www.scopus.com/inward/record.url?scp=84875595086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875595086&partnerID=8YFLogxK

U2 - 10.1016/j.semcancer.2012.12.001

DO - 10.1016/j.semcancer.2012.12.001

M3 - Article

C2 - 23266653

AN - SCOPUS:84875595086

VL - 23

SP - 109

EP - 115

JO - Seminars in Cancer Biology

JF - Seminars in Cancer Biology

SN - 1044-579X

IS - 2

ER -